National Biotechnology and Biomanufacturing Initiative
National Biotechnology and Biomanufacturing Initiative
Revolutionizing Biomanufacturing: Data Management is Key
📊 Biomanufacturing must rethink data management to keep up with the increasing complexity and volume of data generated in the industry. 🏭
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Game-Changing VHH Proteins: Threatening Monoclonal Antibodies?
🔍 VHH proteins could challenge monoclonal antibodies. 💡 They are smaller, simpler, and cheaper, offering advantages in certain applications. 💰💊💪🌍
Revolutionary Technologies Combat Soaring Healthcare Costs
Can new technologies tackle the escalating cost of healthcare? 📅 May 20, 2024: QTL technology and complex systems science offer potential solutions. 👩⚕️👨⚕️
Sartorius and NVIDIA Revolutionize Drug Discovery with AI
📰 Sartorius teams up with NVIDIA to revolutionize drug discovery and manufacturing using AI-powered computing platforms and software. 🧪🖥️💊💡🦠🔬
Scientists Transforming Fermentation Waste into Valuable Materials
🔍 Teesside University scientists ♻️ are researching how to turn fermentation byproducts into valuable char-based materials. 🌱🌍 CircularEconomy
Europe’s Cluster Conference: Boosting Green Digital and Biotech Leadership
💥 More than 900 experts from clusters and the EU Commission gathered in Brussels for the European Cluster Conference. 🌍💪🏼
Revolutionary Ribosome Engineering: Lowering Drug Costs and Fueling the Bioeconomy
💡 Ribosome pool engineering 💊🌱🧬 can transform the bioeconomy by increasing protein synthesis yields and lowering drug manufacturing costs. 🔬🚀
University of Delaware’s Groundbreaking Biomanufacturing Hub Boosts Economic Growth and Innovation
🏗️ The University of Delaware breaks ground on the SABRE Center, a biomanufacturing facility, to boost economic growth in biopharmaceuticals. 💼💰💡🌍🏭💪
Revolutionary Biomethane Reactor Sold to Danish CCU Specialist
📅 Electrochaea GmbH has sold a BioCat bioreactor to Danish CCU specialist Again AS. 👥 Again AS uses CO2-fixing archaea to manufacture carbon-negative chemicals at an industrial scale. 💰 Electrochaea sold the bioreactor to Again AS, enriching its R&D work. ♻️ Electrochaea sets a new industry standard for resource efficiency and adaptive bioreactor technology. ⚡️ Electrochaea's biotechnology produces CO2-neutral synthetic methane as a fossil-free alternative for LNG.
